Cocoa and chocolate in human health and disease

Antioxidants and Redox Signaling

Volumn 15, Issue 10, 2011, Pages 2779-2811

  Katz, David L ^a   Doughty, Kim ^a   Ali, Ather ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; EPICATECHIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; NITRIC OXIDE;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CACAO; CARDIOVASCULAR EFFECT; COGNITION; DIABETES MELLITUS; FOOD INTAKE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MOOD; NERVE INJURY; PRIORITY JOURNAL; REVIEW; SATIETY; SKIN PROTECTION; VASCULAR ENDOTHELIUM; WEIGHT GAIN;

ANTIOXIDANTS; CACAO; DISEASE; HUMANS; REFERENCE VALUES;

THEOBROMA CACAO;

EID: 80054014343     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2010.3697     Document Type: Review

References (289)

1. Actis-Goretta L, Ottaviani JI, and Fraga CG. Inhibition of angiotensin converting enzyme activity by flavanol-rich foods. J Agric Food Chem 54: 229-234, 2006. (Pubitemid 43119944)
2. Actis-Goretta L, Ottaviani JI, Keen CL, and Fraga CG. Inhibition of angiotensin converting enzyme (ACE) activity by flavan-3-ols and procyanidins. FEBS Lett 555: 597-600, 2003. (Pubitemid 37532617)
3. Al-Delaimy WK, Rimm EB, Willett WC, Stampfer MJ, and Hu FB. Magnesium intake and risk of coronary heart disease among men. J Am Coll Nutr 23: 63-70, 2004. (Pubitemid 38200836)
4. Allan SM, and Rothwell NJ. Inflammation in central nervous system injury. Philos Trans R Soc Lond B Biol Sci 358: 1669-1677, 2003. (Pubitemid 37298635)
5. Almoosawi S, Fyfe L, Ho C, and Al-Dujaili E. The effect of polyphenol-rich dark chocolate on fasting capillary whole blood glucose, total cholesterol, blood pressure and glucocorticoids in healthy overweight and obese subjects. Br J Nutr 103: 842-850, 2010.
6. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, Lieberman EH, Ganz P, Creager MA, Yeung AC, et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 26: 1235-1241, 1995.
7. Ando K, Matsui H, Fujita M, and Fujita T. Protective effect of dietary potassium against cardiovascular damage in saltsensitive hypertension: possible role of its antioxidant action. Curr Vasc Pharmacol 8: 59-63, 2010.
8. Andrews RK and Berndt MC. Platelet physiology and thrombosis. Thromb Res 114: 447-453, 2004. (Pubitemid 39422578)
9. Appel LJ, Sacks FM, Carey VJ, Obarzanek E, Swain JF, Miller ER 3rd, Conlin PR, Erlinger TP, Rosner BA, Laranjo NM, Charleston J, McCarron P, and Bishop LM. Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA 294: 2455-2464, 2005. (Pubitemid 41627923)
10. Arlorio M, Bottini C, Travaglia F, Locatelli M, Bordiga M, Coisson JD, Martelli A, and Tessitore L. Protective activity of Theobroma cacao L. phenolic extract on AML12 and MLP29 liver cells by preventing apoptosis and inducing autophagy. J Agric Food Chem 57: 10612-10618, 2009.
11. Arnal JF, Dinh-Xuan AT, Pueyo M, Darblade B, and Rami J. Endothelium-derived nitric oxide and vascular physiology and pathology. Cell Mol Life Sci 55: 1078-1087, 1999. (Pubitemid 29361074)
12. Arts IC, van de Putte B, and Hollman PC. Catechin contents of foods commonly consumed in The Netherlands. 1. Fruits, vegetables, staple foods, and processed foods. J Agric Food Chem 48: 1746-1751, 2000. (Pubitemid 30331519)
13. Baba S, Natsume M, Yasuda A, Nakamura Y, Tamura T, Osakabe N, Kanegae M, and Kondo K. Plasma LDL and HDL cholesterol and oxidized LDL concentrations are altered in normo-and hypercholesterolemic humans after intake of different levels of cocoa powder. J Nutr 137: 1436-1441, 2007. (Pubitemid 46855482)
14. Baba S, Osakabe N, Kato Y, Natsume M, Yasuda A, Kido T, Fukuda K, Muto Y, and Kondo K. Continuous intake of polyphenolic compounds containing cocoa powder reduces LDL oxidative susceptibility and has beneficial effects on plasma HDL-cholesterol concentrations in humans. Am J Clin Nutr 85: 709-717, 2007. (Pubitemid 46393501)
15. Baba S, Osakabe N, Natsume M, and Terao J. Absorption and urinary excretion of procyanidin B2 [epicatechin-(4beta-8)-epicatechin] in rats. Free Radic Biol Med 33: 142-148, 2002. (Pubitemid 34681016)
16. Balzer J, Rassaf T, Heiss C, Kleinbongard P, Lauer T, Merx M, Heussen N, Gross HB, Keen CL, Schroeter H, and Kelm M. Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients a double-masked, randomized, controlled trial. J Am Coll Cardiol 51: 2141-2149, 2008. (Pubitemid 351713684)
17. Barry Callebaut USA, Inc. 2007. Barry Callebaut survey finds Americans love milk chocolate but are experimenting with other varieties. www.barry-callebaut.com/56?release = 3400, accessed May 12, 2010.
18. Bazzano LA. Effects of soluble dietary fiber on low-density lipoprotein cholesterol and coronary heart disease risk. Curr Atheroscler Rep 10: 473-477, 2008.
19. Belscak-Cvitanovic A, Benkovic M, Komes D, Bauman I, Horzic D, Dujmic F, and Matijasec M. Physical properties and bioactive constituents of powdered mixtures and drinks prepared with cocoa and various sweeteners. J Agric Food Chem 58: 7187-7195, 2010.
20. Berry NM, Davison K, Coates AM, Buckley JD, and Howe PR. Impact of cocoa flavanol consumption on blood pressure responsiveness to exercise. Br J Nutr 103: 1-5, 2010.
21. Boelsma E, van de Vijver LP, Goldbohm RA, Klopping-Ketelaars IA, Hendriks HF, and Roza L. Human skin condition and its associations with nutrient concentrations in serum and diet. Am J Clin Nutr 77: 348-355, 2003. (Pubitemid 36133376)
22. Bordeaux B, Yanek LR, Moy TF, White LW, Becker LC, Faraday N, and Becker DM. Casual chocolate consumption and inhibition of platelet function. Prev Cardiol 10: 175-180, 2007.
23. Bourtchuladze R, Frenguelli B, Blendy J, Cioffi D, Schutz G, and Silva AJ. Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein. Cell 79: 59-68, 1994.
24. Bowe WP, Joshi SS, and Shalita AR. Diet and acne. J Am Acad Dermatol 63: 124-141, 2010.
25. Bracco U. Effect of triglyceride structure on fat absorption. Am J Clin Nutr 60: 1002S-1009S, 1994.
26. Bruinsma K and Taren DL. Chocolate: food or drug? J Am Diet Assoc 99: 1249-1256, 1999. (Pubitemid 29480618)
27. Brummer P. Coronary mortality and living standard. II. Coffee, tea, cocoa, alcohol and tobacco. Acta Med Scand 186: 61-63, 1969.
28. Buijsse B, Feskens EJ, Kok FJ, and Kromhout D. Cocoa intake, blood pressure, and cardiovascular mortality: the Zutphen elderly study. Arch Intern Med 166: 411-417, 2006.
29. Buijsse B, Weikert C, Drogan D, Bergmann M, and Boeing H. Chocolate consumption in relation to blood pressure and risk of cardiovascular disease in German adults. Eur Heart J 31: 1616-1623, 2010.
30. Busse R and Fleming I. Endothelial dysfunction in atherosclerosis. J Vasc Res 33: 181-194, 1996. (Pubitemid 26164469)
31. Buyken AE, Flood V, Rochtchina E, Nestel P, Brand-Miller J, and Mitchell P. Modifications in dietary fat quality are associated with changes in serum lipids of older adults independently of lipid medication. J Nutr 140: 88-94, 2010.
32. CAOBISCO. Ranking of Consumption (Chocolate Confectionery). www.caobisco.com/doc-uploads/Charts/ranking-of-consumption-chocolate- confectionery-2007.pdf, accessed Jan 5, 2010.
33. Celermajer DS, Sorensen KE, Bull C, Robinson J, and Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 24: 1468-1474, 1994. (Pubitemid 24344241)
34. Ceriello A and Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 24: 816-823, 2004. (Pubitemid 38620857)
35. Chakraborti S, Chakraborti T, Mandal M, Mandal A, Das S, and Ghosh S. Protective role of magnesium in cardiovascular diseases: a review. Mol Cell Biochem 238: 163-179, 2002. (Pubitemid 35023539)
36. Chakravarthy BK, Gupta S, and Gode KD. Functional beta cell regeneration in the islets of pancreas in alloxan induced diabetic rats by (f)-epicatechin. Life Sci 31: 2693-2697, 1982. (Pubitemid 13190740)
37. Chen D, Daniel KG, Kuhn DJ, Kazi A, Bhuiyan M, Li L, Wang Z, Wan SB, Lam WH, Chan TH, and Dou QP. Green tea and tea polyphenols in cancer prevention. Front Biosci 9: 2618-2631, 2004.
38. Chevaux KA JL, Villar ME, et al. Proximate, mineral and procyanidin content of certain foods and beverages consumed by the Kuna Amerinds of Panama. J Food Comp Anal 14: 553-563, 2001.
39. Cooper KA, Campos-Gimenez E, Jimenez Alvarez D, Nagy K, Donovan JL, and Williamson G. Rapid reversed phase ultra-performance liquid chromatography analysis of the major cocoa polyphenols and inter-relationships of their concentrations in chocolate. J Agric Food Chem 55: 2841-2847, 2007. (Pubitemid 46668287)
40. Cooper KA, Donovan JL, Waterhouse AL, and Williamson G. Cocoa and health: a decade of research. Br J Nutr 99: 1-11, 2008. (Pubitemid 350286132)
41. Corti R, Flammer AJ, Hollenberg NK, and Luscher TF. Cocoa and cardiovascular health. Circulation 119: 1433-1441, 2009.
42. Corti R, Hutter R, Badimon JJ, and Fuster V. Evolving concepts in the triad of atherosclerosis, inflammation and thrombosis. J Thromb Thrombolysis 17: 35-44, 2004. (Pubitemid 39069460)
43. Cotelle N. Role of flavonoids in oxidative stress. Curr Top Med Chem 1: 569-590, 2001.
44. Crews WD Jr., Harrison DW, and Wright JW. A doubleblind, placebo-controlled, randomized trial of the effects of dark chocolate and cocoa on variables associated with neuropsychological functioning and cardiovascular health: clinical findings from a sample of healthy, cognitively intact older adults. Am J Clin Nutr 87: 872-880, 2008. (Pubitemid 351549231)
45. D'Archivio M, Filesi C, Vari R, Scazzocchio B, and Masella R. Bioavailability of the polyphenols: status and controversies. Int J Mol Sci 11: 1321-1342, 2010.
46. Davidovici BB and Wolf R. The role of diet in acne: facts and controversies. Clin Dermatol 28: 12-16, 2010.
47. Davison K, Berry NM, Misan G, Coates AM, Buckley JD, and Howe PR. Dose-related effects of flavanol-rich cocoa on blood pressure. J Hum Hypertens 24: 568-576, 2010.
48. Davison K, Coates AM, Buckley JD, and Howe PR. Effect of cocoa flavanols and exercise on cardiometabolic risk factors in overweight and obese subjects. Int J Obes (Lond) 32: 1289-1296, 2008.
49. De Benoist B, Mclean E, Egli I, and Cogswell M. Worldwide Prevalence of Anaemia 1993-2005. Geneva: World Health Organization, 2008.
50. De Caterina R, Zampolli A, Del Turco S, Madonna R, and Massaro M. Nutritional mechanisms that influence cardiovascular disease. Am J Clin Nutr 83: 421S-426S, 2006. (Pubitemid 44713212)
51. Deanfield JE, Halcox JP, and Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation 115: 1285-1295, 2007. (Pubitemid 46594773)
52. Delva P. Magnesium and coronary heart disease. Mol Aspects Med 24: 63-78, 2003. (Pubitemid 36092145)
53. Deprez S, Mila I, Huneau JF, Tome D, and Scalbert A. Transport of proanthocyanidin dimer, trimer, and polymer across monolayers of human intestinal epithelial Caco-2 cells. Antioxid Redox Signal 3: 957-967, 2001. (Pubitemid 34027356)
54. Desch S, Kobler D, Schmidt J, Sonnabend M, Adams V, Sareban M, Eitel I, Bluher M, Schuler G, and Thiele H. Low vs. higher-dose dark chocolate and blood pressure in cardiovascular high-risk patients. Am J Hypertens 23: 694-700, 2010.
55. Desch S, Schmidt J, Kobler D, Sonnabend M, Eitel I, Sareban M, Rahimi K, Schuler G, and Thiele H. Effect of cocoa products on blood pressure: systematic review and metaanalysis. Am J Hypertens 23: 97-103, 2010.
56. Desjardins F and Balligand JL. Nitric oxide-dependent endothelial function and cardiovascular disease. Acta Clin Belg 61: 326-334, 2006.
57. DeVault KR, Castell DO, and American College of G. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 100: 190-200, 2005. (Pubitemid 41623288)
58. di Giuseppe R, Di Castelnuovo A, Centritto F, Zito F, De Curtis A, Costanzo S, Vohnout B, Sieri S, Krogh V, Donati MB, de Gaetano G, and Iacoviello L. Regular consumption of dark chocolate is associated with low serum concentrations of C-reactive protein in a healthy Italian population. J Nutr 138: 1939-1945, 2008.
59. Dillinger TL, Barriga P, Escarcega S, Jimenez M, Salazar Lowe D, and Grivetti LE. Food of the gods: cure for humanity? A cultural history of the medicinal and ritual use of chocolate. J Nutr 130: 2057S-7072S, 2000.
60. Djousse L, Hopkins PN, Arnett DK, Pankow JS, Borecki I, North KE, and Curtis Ellison R. Chocolate consumption is inversely associated with calcified atherosclerotic plaque in the coronary arteries: The NHLBI Family Heart Study. Clin Nutr 30: 38-43, 2011.
61. Donovan JL, Manach C, Rios L, Morand C, Scalbert A, and Remesy C. Procyanidins are not bioavailable in rats fed a single meal containing a grapeseed extract or the procyanidin dimer B3. Br J Nutr 87: 299-306, 2002. (Pubitemid 34441169)
62. Ehara S, Ueda M, Naruko T, Haze K, Itoh A, Otsuka M, Komatsu R, Matsuo T, Itabe H, Takano T, Tsukamoto Y, Yoshiyama M, Takeuchi K, Yoshikawa J, and Becker AE. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 103: 1955-1960, 2001. (Pubitemid 32322222)
63. Engler MB and Engler MM. The emerging role of flavonoid-rich cocoa and chocolate in cardiovascular health and disease. Nutr Rev 64: 109-118, 2006.
64. Engler MB, Engler MM, Chen CY, Malloy MJ, Browne A, Chiu EY, Kwak HK, Milbury P, Paul SM, Blumberg J, and Mietus-Snyder ML. Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults. J AmColl Nutr 23: 197-204, 2004. (Pubitemid 38746107)
65. Faridi Z, Njike VY, Dutta S, Ali A, and Katz DL. Acute dark chocolate and cocoa ingestion and endothelial function: a randomized controlled crossover trial. Am J Clin Nutr 88: 58-63, 2008. (Pubitemid 351988683)
66. Farouque HM, Leung M, Hope SA, Baldi M, Schechter C, Cameron JD, and Meredith IT. Acute and chronic effects of flavanol-rich cocoa on vascular function in subjects with coronary artery disease: a randomized double-blind placebo-controlled study. Clin Sci (Lond) 111: 71-80, 2006. (Pubitemid 44023413)
67. Fathi R, Haluska B, Isbel N, Short L, and Marwick TH. The relative importance of vascular structure and function in predicting cardiovascular events. J Am Coll Cardiol 43: 616-623, 2004. (Pubitemid 38229534)
68. Federico A, Morgillo F, Tuccillo C, Ciardiello F, and Loguercio C. Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer 121: 2381-2386, 2007. (Pubitemid 350022406)
69. Ferdowsian HR and Levin S. Does diet really affect acne? Skin Therapy Lett 15: 1-25, 2010.
70. Fernandez ML. Soluble fiber and nondigestible carbohydrate effects on plasma lipids and cardiovascular risk. Curr Opin Lipidol 12: 35-40, 2001.
71. Fisher ND and Hollenberg NK. Aging and vascular responses to flavanol-rich cocoa. J Hypertens 24: 1575-1580, 2006. (Pubitemid 44162459)
72. Fisher ND, Hughes M, Gerhard-Herman M, and Hollenberg NK. Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans. JHypertens 21: 2281-2286, 2003. (Pubitemid 38293567)
73. Fisher ND, Sorond FA, and Hollenberg NK. Cocoa flavanols and brain perfusion. J Cardiovasc Pharmacol 47 Suppl 2: S210-S214, 2006. (Pubitemid 44620213)
74. Flammer AJ, Hermann F, Sudano I, Spieker L, Hermann M, Cooper KA, Serafini M, Luscher TF, Ruschitzka F, Noll G, and Corti R. Dark chocolate improves coronary vasomotion and reduces platelet reactivity. Circulation 116: 2376-2382, 2007. (Pubitemid 350145072)
75. Ford ES, Bergmann MM, Kroger J, Schienkiewitz A, Weikert C, and Boeing H. Healthy living is the best revenge: findings from the European Prospective Investigation into Cancer and Nutrition-Potsdam study. Arch Intern Med 169: 1355-1362, 2009.
76. Francis ST, Head K, Morris PG, and Macdonald IA. The effect of flavanol-rich cocoa on the fMRI response to a cognitive task in healthy young people. J Cardiovasc Pharmacol 47 Suppl 2: S215-S220, 2006. (Pubitemid 44620214)
77. Franco OH, Bonneux L, de Laet C, Peeters A, Steyerberg EW, and Mackenbach JP. The Polymeal: a more natural, safer, and probably tastier (than the Polypill) strategy to reduce cardiovascular disease by more than 75%. BMJ 329: 1447-1450, 2004. (Pubitemid 40007106)
78. Friedman M, Levin CE, Lee SU, and Kozukue N. Stability of green tea catechins in commercial tea leaves during storage for 6 months. J Food Sci 74: H47-H51, 2009.
79. Gewaltig MT and Kojda G. Vasoprotection by nitric oxide: mechanisms and therapeutic potential. Cardiovasc Res 55: 250-260, 2002. (Pubitemid 34775275)
80. Ghosh D and Scheepens A. Vascular action of polyphenols. Mol Nutr Food Res 53: 322-331, 2009.
81. Gibb CM, Davies PT, Glover V, Steiner TJ, Clifford Rose F, and Sandler M. Chocolate is a migraine-provoking agent. Cephalalgia 11: 93-95, 1991.
82. Grassi D, Desideri G, and Ferri C. Blood pressure and cardiovascular risk: what about cocoa and chocolate? Arch Biochem Biophys 501: 112-115, 2010.
83. Grassi D, Desideri G, Necozione S, Lippi C, Casale R, Properzi G, Blumberg JB, and Ferri C. Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming highpolyphenol dark chocolate. J Nutr 138: 1671-1676, 2008.
84. Grassi D, Necozione S, Lippi C, Croce G, Valeri L, Pasqualetti P, Desideri G, Blumberg JB, and Ferri C. Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension 46: 398-405, 2005. (Pubitemid 41099176)
85. Gu L, House SE, Wu X, Ou B, and Prior RL. Procyanidin and catechin contents and antioxidant capacity of cocoa and chocolate products. J Agric Food Chem 54: 4057-4061, 2006. (Pubitemid 44030590)
86. Gums JG. Magnesium in cardiovascular and other disorders. Am J Health Syst Pharm 61: 1569-1576, 2004. (Pubitemid 39481397)
87. Gurbel PA and Serebruany VL. Adhesion molecules, platelet activation, and cardiovascular risk. Am Heart J 143: 196-198, 2002.
88. Hamed MS, Gambert S, Bliden KP, Bailon O, Singla A, Antonino MJ, Hamed F, Tantry US, and Gurbel PA. Dark chocolate effect on platelet activity, C-reactive protein and lipid profile: a pilot study. South Med J 101: 1203-1208, 2008.
89. Hanhineva K, Torronen R, Bondia-Pons I, Pekkinen J, Kolehmainen M, Mykkanen H, and Poutanen K. Impact of dietary polyphenols on carbohydrate metabolism. Int J Mol Sci 11: 1365-1402, 2010.
90. Heinrich U, Neukam K, Tronnier H, Sies H, and Stahl W. Long-term ingestion of high flavanol cocoa provides photoprotection against UV-induced erythema and improves skin condition in women. J Nutr 136: 1565-1569, 2006. (Pubitemid 43765363)
91. Heiss C, Dejam A, Kleinbongard P, Schewe T, Sies H, and Kelm M. Vascular effects of cocoa rich in flavan-3-ols. JAMA 290: 1030-1031, 2003. (Pubitemid 37430442)
92. Heiss C, Finis D, Kleinbongard P, Hoffmann A, Rassaf T, Kelm M, and Sies H. Sustained increase in flow-mediated dilation after daily intake of high-flavanol cocoa drink over 1 week. J Cardiovasc Pharmacol 49: 74-80, 2007.
93. Heiss C, Jahn S, Taylor M, Real WM, Angeli FS, Wong ML, Amabile N, Prasad M, Rassaf T, Ottaviani JI, Mihardja S, Keen CL, Springer ML, Boyle A, Grossman W, Glantz SA, Schroeter H, and Yeghiazarians Y. Improvement of endothelial function with dietary flavanols is associated with mobilization of circulating angiogenic cells in patients with coronary artery disease. J Am Coll Cardiol 56: 218-224, 2010.
94. Heiss C, Kleinbongard P, Dejam A, Perre S, Schroeter H, Sies H, and Kelm M. Acute consumption of flavanol-rich cocoa and the reversal of endothelial dysfunction in smokers. J Am Coll Cardiol 46: 1276-1283, 2005. (Pubitemid 41615549)
95. Heptinstall S, May J, Fox S, Kwik-Uribe C, and Zhao L. Cocoa flavanols and platelet and leukocyte function: recent in vitro and ex vivo studies in healthy adults. J Cardiovasc Pharmacol 47 Suppl 2: S197-S205; discussion S206-S209, 2006. (Pubitemid 44620211)
96. Hermann F, Spieker LE, Ruschitzka F, Sudano I, Hermann M, Binggeli C, Luscher TF, Riesen W, Noll G, and Corti R. Dark chocolate improves endothelial and platelet function. Heart 92: 119-120, 2006. (Pubitemid 43021877)
97. Hertog MG, Kromhout D, Aravanis C, Blackburn H, Buzina R, Fidanza F, Giampaoli S, Jansen A, Menotti A, Nedeljkovic S, and et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med 155: 381-386, 1995.
98. Hetts SW. To die or not to die: an overview of apoptosis and its role in disease. JAMA 279: 300-307, 1998. (Pubitemid 28071022)
99. Hii CS and Howell SL. Effects of flavonoids on insulin secretion and 45Ca2f handling in rat islets of Langerhans. J Endocrinol 107: 1-8, 1985. (Pubitemid 16247388)
100. Hill AJ and Heaton-Brown L. The experience of food craving: a prospective investigation in healthy women. J Psychosom Res 38: 801-814, 1994.
101. Hollenberg N. Vascular action of cocoa flavanols in humans: the roots of the story. J Cardiovasc Pharmacol 47 Suppl 2: S99-S102; discussion S119-S121, 2006. (Pubitemid 44620198)
102. Hollenberg NK, Fisher ND, and McCullough ML. Flavanols, the Kuna, cocoa consumption, and nitric oxide. J Am Soc Hypertens 3: 105-112, 2009.
103. Hollenberg NK, Martinez G, McCullough M, Meinking T, Passan D, Preston M, Rivera A, Taplin D, and Vicaria-Clement M. Aging, acculturation, salt intake, and hypertension in the Kuna of Panama. Hypertension 29: 171-176, 1997. (Pubitemid 27074039)
104. Holt RR, Actis-Goretta L, Momma TY, and Keen CL. Dietary flavanols and platelet reactivity. J Cardiovasc Pharmacol 47 Suppl 2: S187-S196; discussion S206-S209, 2006. (Pubitemid 44620210)
105. Holt RR, Lazarus SA, Sullards MC, Zhu QY, Schramm DD, Hammerstone JF, Fraga CG, Schmitz HH, and Keen CL. Procyanidin dimer B2 [epicatechin-(4beta-8)- epicatechin] in human plasma after the consumption of a flavanol-rich cocoa. Am J Clin Nutr 76: 798-804, 2002.
106. Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, Le Cornu KA, Ryder JJ, Hall WL, and Cassidy A. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a metaanalysis of randomized controlled trials. Am J Clin Nutr 88: 38-50, 2008. (Pubitemid 351988681)
107. Hormes JM and Rozin P. Perimenstrual chocolate craving. What happens after menopause? Appetite 53: 256-259, 2009.
108. Hu FB and Malik VS. Sugar-sweetened beverages and risk of obesity and type 2 diabetes: epidemiologic evidence. Physiol Behav 100: 47-54, 2010.
109. Huang H, Mai W, Liu D, Hao Y, Tao J, and Dong Y. The oxidation ratio of LDL: a predictor for coronary artery disease. Dis Markers 24: 341-349, 2008.
110. Hunot S and Hirsch EC. Neuroinflammatory processes in Parkinson's disease. Ann Neurol 53 Suppl 3: S49-S58; discussion S58-S60, 2003.
111. Hunter JE, Zhang J, and Kris-Etherton PM. Cardiovascular disease risk of dietary stearic acid compared with trans, other saturated, and unsaturated fatty acids: a systematic review. Am J Clin Nutr 91: 46-63, 2010.
112. Hurst WJ, Payne MJ, Miller KB, and Stuart DA. Stability of cocoa antioxidants and flavan-3-ols over time. J Agric Food Chem 57: 9547-9550, 2009.
113. International Cocoa Organization. Annual Forecasts of Production and Consumption and Estimates of Production Levels to Achieve Equilibrium in the World Cocoa Market. 2008. www.icco.org/Attachment.aspx?Id=fgn64825. Accessed May 10, 2010.
114. Ishikawa A, Yamashita H, Hiemori M, Inagaki E, Kimoto M, Okamoto M, Tsuji H, Memon AN, Mohammadio A, and Natori Y. Characterization of inhibitors of postprandial hyperglycemia from the leaves of Nerium indicum. J Nutr Sci Vitaminol (Tokyo) 53: 166-173, 2007. (Pubitemid 46933027)
115. Jalil AM, Ismail A, Pei CP, Hamid M, and Kamaruddin SH. Effects of cocoa extract on glucometabolism, oxidative stress, and antioxidant enzymes in obese-diabetic (Ob-db) rats. J Agric Food Chem 56: 7877-7884, 2008.
116. Janszky I, Mukamal KJ, Ljung R, Ahnve S, Ahlbom A, and Hallqvist J. Chocolate consumption and mortality following a first acute myocardial infarction: the Stockholm Heart Epidemiology Program. J Intern Med 266: 248-257, 2009.
117. Jenkins DJ, Kendall CW, Vuksan V, Vidgen E, Wong E, Augustin LS, and Fulgoni V 3rd. Effect of cocoa bran on low-density lipoprotein oxidation and fecal bulking. Arch Intern Med 160: 2374-2379, 2000.
118. Jeong SY and Seol DW. The role of mitochondria in apoptosis. BMB Rep 41: 11-22, 2008.
119. Jia L, Liu X, Bai YY, Li SH, Sun K, He C, and Hui R. Shortterm effect of cocoa product consuption on lipid profile: a meta-analysis of randomized controlled trials. Am J Clin Nutr 92: 218-225, 2010.
120. Jobgen WS, Fried SK, Fu WJ, Meininger CJ, and Wu G. Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates. J Nutr Biochem 17: 571-588, 2006. (Pubitemid 44205442)
121. Johnston K, Sharp P, Clifford M, and Morgan L. Dietary polyphenols decrease glucose uptake by human intestinal Caco-2 cells. FEBS Lett 579: 1653-1657, 2005. (Pubitemid 40341538)
122. Joseph JA, Shukitt-Hale B, Denisova NA, Bielinski D, Martin A, McEwen JJ, and Bickford PC. Reversals of agerelated declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J Neurosci 19: 8114-8121, 1999. (Pubitemid 30225807)
123. Kaltenbach T, Crockett S, and Gerson LB. Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach. Arch Intern Med 166: 965-971, 2006.
124. Katan MB, Zock PL, and Mensink RP. Effects of fats and fatty acids on blood lipids in humans: an overview. Am J Clin Nutr 60: 1017S-1022S, 1994.
125. Katz DL. Life and death, knowledge and power: why knowing what matters is not what's the matter. Arch Intern Med 169: 1362-1363, 2009.
126. Kenny TP, Keen CL, Schmitz HH, and Gershwin ME. Immune effects of cocoa procyanidin oligomers on peripheral blood mononuclear cells. Exp Biol Med (Maywood) 232: 293-300, 2007. (Pubitemid 46203298)
127. Kenny TP, Shu SA, Moritoki Y, Keen CL, and Gershwin ME. Cocoa flavanols and procyanidins can modulate the lipopolysaccharide activation of polymorphonuclear cells in vitro. J Med Food 12: 1-7, 2009.
128. Keogh JB, Grieger JA, Noakes M, and Clifton PM. Flowmediated dilatation is impaired by a high-saturated fat diet but not by a high-carbohydrate diet. Arterioscler Thromb Vasc Biol 25: 1274-1279, 2005. (Pubitemid 40776621)
129. Keogh JB, McInerney J, and Clifton PM. The effect of milk protein on the bioavailability of cocoa polyphenols. J Food Sci 72: S230-S233, 2007. (Pubitemid 46558141)
130. Khan N, Afaq F, and Mukhtar H. Apoptosis by dietary factors: the suicide solution for delaying cancer growth. Carcinogenesis 28: 233-239, 2007. (Pubitemid 46321838)
131. Kim JA, Montagnani M, Koh KK, and Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 113: 1888-1904, 2006. (Pubitemid 43739401)
132. Kim JE, Son JE, Jung SK, Kang NJ, Lee CY, Lee KW, and Lee HJ. Cocoa polyphenols suppress TNF-alpha-induced vascular endothelial growth factor expression by inhibiting phosphoinositide 3-kinase (PI3K) and mitogen-activated protein kinase kinase-1 (MEK1) activities in mouse epidermal cells. Br J Nutr 104: 957-964, 2010.
133. Kim YS and Joh TH. Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease. Exp Mol Med 38: 333-347, 2006.
134. Klevay LM. Cardiovascular disease from copper deficiency-a history. J Nutr 130: 489S-492S, 2000. (Pubitemid 30073780)
135. Kris-Etherton PM, Derr JA, Mustad VA, Seligson FH, and Pearson TA. Effects of a milk chocolate bar per day substituted for a high-carbohydrate snack in young men on an NCEP/AHA Step 1 Diet. Am J Clin Nutr 60: 1037S-1042S, 1994.
136. Kris-Etherton PM, and Keen CL. Evidence that the antioxidant flavonoids in tea and cocoa are beneficial for cardiovascular health. Curr Opin Lipidol 13: 41-49, 2002. (Pubitemid 34174628)
137. Kwon do Y, Choi KH, Kim SJ, Choi DW, Kim YS, and Kim YC. Comparison of peroxyl radical scavenging capacity of commonly consumed beverages. Arch Pharm Res 32: 283-287, 2009.
138. Lavoie JL and Sigmund CD. Minireview: overview of the renin-angiotensin system-an endocrine and paracrine system. Endocrinology 144: 2179-2183, 2003. (Pubitemid 36629863)
139. Lecumberri E, Mateos R, Ramos S, Alia M, Ruperez P, Goya L, Izquierdo-Pulido M, and Bravo L. Characterization of cocoa fiber and its effect on the antioxidant capacity of serum in rats]. Nutr Hosp 21: 622-628, 2006. (Pubitemid 44663106)
140. Lee IK, Kim HS, and Bae JH. Endothelial dysfunction: its relationship with acute hyperglycaemia and hyperlipidemia. Int J Clin Pract Suppl 129: 59-64, 2002.
141. Lee KW, Kundu JK, Kim SO, Chun KS, Lee HJ, and Surh YJ. Cocoa polyphenols inhibit phorbol ester-induced superoxide anion formation in cultured HL-60 cells and expression of cyclooxygenase-2 and activation of NFkappaB and MAPKs in mouse skin in vivo. J Nutr 136: 1150-1155, 2006.
142. Leone N, Courbon D, Ducimetiere P, and Zureik M. Zinc, copper, and magnesium and risks for all-cause, cancer, and cardiovascular mortality. Epidemiology 17: 308-314, 2006.
143. Li H and Forstermann U. Prevention of atherosclerosis by interference with the vascular nitric oxide system. Curr Pharm Des 15: 3133-3145, 2009.
144. Loke WM, Hodgson JM, Proudfoot JM, McKinley AJ, Puddey IB, and Croft KD. Pure dietary flavonoids quercetin and (f)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. Am J Clin Nutr 88: 1018-1025, 2008.
145. Luscher TF and Barton M. Biology of the endothelium. Clin Cardiol 20: II-3-II-10, 1997. (Pubitemid 28009557)
146. Macht M and Dettmer D. Everyday mood and emotions after eating a chocolate bar or an apple. Appetite 46: 332-336, 2006. (Pubitemid 43867824)
147. Macht M and Mueller J. Immediate effects of chocolate on experimentally inducedmood states. Appetite 49: 667-674, 2007. (Pubitemid 350030342)
148. Macht M and Mueller J. Interactive effects of emotional and restrained eating on responses to chocolate and affect. J Nerv Ment Dis 195: 1024-1026, 2007. (Pubitemid 350306557)
149. Mackenzie GG, Carrasquedo F, Delfino JM, Keen CL, Fraga CG, and Oteiza PI. Epicatechin, catechin, and dimeric procyanidins inhibit PMA-induced NF-kappaB activation at multiple steps in Jurkat T cells. FASEB J 18: 167-169, 2004.
150. Manach C, Scalbert A, Morand C, Remesy C, and Jimenez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 79: 727-747, 2004. (Pubitemid 41103873)
151. Manach C, Williamson G, Morand C, Scalbert A, and Remesy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81: 230S-242S, 2005.
152. Mao TK, Van de Water J, Keen CL, Schmitz HH, and Gershwin ME. Effect of cocoa flavanols and their related oligomers on the secretion of interleukin-5 in peripheral blood mononuclear cells. J Med Food 5: 17-22, 2002. (Pubitemid 34462797)
153. Marcus DA, Scharff L, Turk D, and Gourley LM. A doubleblind provocative study of chocolate as a trigger of headache. Cephalalgia 17: 855-862; discussion 800, 1997. (Pubitemid 28034350)
154. Martin FP, Rezzi S, Pere-Trepat E, Kamlage B, Collino S, Leibold E, Kastler J, Rein D, Fay LB, and Kochhar S. Metabolic effects of dark chocolate consumption on energy, gut microbiota, and stress-related metabolism in free-living subjects. J Proteome Res 8: 5568-5579, 2009.
155. Maskarinec G. Cancer protective properties of cocoa: a review of the epidemiologic evidence. Nutr Cancer 61: 573-579, 2009.
156. Massolt ET, van Haard PM, Rehfeld JF, Posthuma EF, van der Veer E, and Schweitzer DH. Appetite suppression through smelling of dark chocolate correlates with changes in ghrelin in young women. Regul Pept 161: 81-86, 2010.
157. Matsui N, Ito R, Nishimura E, Yoshikawa M, Kato M, Kamei M, Shibata H, Matsumoto I, Abe K, and Hashizume S. Ingested cocoa can prevent high-fat diet-induced obesity by regulating the expression of genes for fatty acid metabolism. Nutrition 21: 594-601, 2005. (Pubitemid 40585860)
158. May AE, Seizer P, and Gawaz M. Platelets: inflammatory firebugs of vascular walls. Arterioscler Thromb Vasc Biol 28: s5-s10, 2008.
159. Maytin M, Leopold J, and Loscalzo J. Oxidant stress in the vasculature. Curr Atheroscler Rep 1: 156-164, 1999.
160. McCulloch J and Harper AM. Phenylethylamine and cerebral blood flow. Possible involvement of phenylethylamine in migraine. Neurology 27: 817-821, 1977. (Pubitemid 8183203)
161. McCulloch J and Harper AM. Factors influencing the response of the cerebral circulation to phenylethylamine. Neurology 29: 201-207, 1979. (Pubitemid 9098488)
162. McCullough ML, Chevaux K, Jackson L, Preston M, Martinez G, Schmitz HH, Coletti C, Campos H, and Hollenberg NK. Hypertension, the Kuna, and the epidemiology of flavanols. J Cardiovasc Pharmacol 47 Suppl 2: S103-S109; discussion 119-121, 2006. (Pubitemid 44620199)
163. McShea A, Leissle K, and Smith MA. The essence of chocolate: a rich, dark, and well-kept secret. Nutrition 25: 1104-1105, 2009.
164. McShea A, Ramiro-Puig E, Munro SB, Casadesus G, Castell M, and Smith MA. Clinical benefit and preservation of flavonols in dark chocolate manufacturing. Nutr Rev 66: 630-641, 2008.
165. Mehrinfar R and Frishman WH. Flavanol-rich cocoa: a cardioprotective nutraceutical. Cardiol Rev 16: 109-115, 2008.
166. Mellor DD, Sathyapalan T, Kilpatrick ES, Beckett S, and Atkin SL. High-cocoa polyphenol-rich chocolate improves HDL cholesterol in type 2 diabetes patients. Diabet Med 27: 1318-1321, 2010.
167. Michener W and Rozin P. Pharmacological versus sensory factors in the satiation of chocolate craving. Physiol Behav 56: 419-422, 1994. (Pubitemid 24269562)
168. Miller KB, Hurst WJ, Flannigan N, Ou B, Lee CY, Smith N, and Stuart DA. Survey of commercially available chocolateand cocoa-containing products in the United States. 2. Comparison of flavan-3-ol content with nonfat cocoa solids, total polyphenols, and percent cacao. J Agric Food Chem 57: 9169-9180, 2009.
169. Miller KB, Hurst WJ, Payne MJ, Stuart DA, Apgar J, Sweigart DS, and Ou B. Impact of alkalization on the antioxidant and flavanol content of commercial cocoa powders. J Agric Food Chem 56: 8527-8533, 2008.
170. Miller KB, Stuart DA, Smith NL, Lee CY, McHale NL, Flanagan JA, Ou B, and Hurst WJ. Antioxidant activity and polyphenol and procyanidin contents of selected commercially available cocoa-containing and chocolate products in the United States. J Agric Food Chem 54: 4062-4068, 2006. (Pubitemid 44030591)
171. Mitchell JA, Ali F, Bailey L, Moreno L, and Harrington LS. Role of nitric oxide and prostacyclin as vasoactive hormones released by the endothelium. Exp Physiol 93: 141-147, 2008. (Pubitemid 350293980)
172. Monagas M, Khan N, Andres-Lacueva C, Casas R, Urpi-Sarda M, Llorach R, Lamuela-Raventos RM, and Estruch R. Effect of cocoa powder on the modulation of inflammatory biomarkers in patients at high risk of cardiovascular disease. Am J Clin Nutr 90: 1144-1150, 2009.
173. Moncada S and Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 329: 2002-2012, 1993. (Pubitemid 24015045)
174. Moncada S, Palmer RM, and Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142, 1991.
175. Mostofsky E, Levitan EB, Wolk A, and Mittleman MA. Chocolate intake and incidence of heart failure: a population-based, prospective study of middle-aged and elderly women. Circ Heart Fail 3: 612-616, 2010.
176. Mullen W, Borges G, Donovan JL, Edwards CA, Serafini M, Lean ME, and Crozier A. Milk decreases urinary excretion but not plasma pharmacokinetics of cocoa flavan-3-ol metabolites in humans. Am J Clin Nutr 89: 1784-1791, 2009.
177. Muller-Lissner SA, Kaatz V, Brandt W, Keller J, and Layer P. The perceived effect of various foods and beverages on stool consistency. Eur J Gastroenterol Hepatol 17: 109-112, 2005. (Pubitemid 40128934)
178. Muniyappa R, Hall G, Kolodziej TL, Karne RJ, Crandon SK, and Quon MJ. Cocoa consumption for 2wk enhances insulin-mediated vasodilatation without improving blood pressure or insulin resistance in essential hypertension. Am J Clin Nutr 88: 1685-1696, 2008.
179. Murphy DW and Castell DO. Chocolate and heartburn: evidence of increased esophageal acid exposure after chocolate ingestion. Am J Gastroenterol 83: 633-636, 1988.
180. Murphy KJ, Chronopoulos AK, Singh I, Francis MA, Moriarty H, Pike MJ, Turner AH, Mann NJ, and Sinclair AJ. Dietary flavanols and procyanidin oligomers from cocoa (Theobroma cacao) inhibit platelet function. Am J Clin Nutr 77: 1466-1473, 2003. (Pubitemid 39655281)
181. Mursu J, Voutilainen S, Nurmi T, Rissanen TH, Virtanen JK, Kaikkonen J, Nyyssonen K, and Salonen JT. Dark chocolate consumption increases HDL cholesterol concentration and chocolate fatty acids may inhibit lipid peroxidation in healthy humans. Free Radic Biol Med 37: 1351-1359, 2004. (Pubitemid 39359157)
182. Myung SK, Ju W, Choi HJ, and Kim SC. Soy intake and risk of endocrine-related gynaecological cancer: a meta-analysis. BJOG 116: 1697-1705, 2009.
183. Napoli C and Ignarro LJ. Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases. Arch Pharm Res 32: 1103-1108, 2009.
184. National Academy of Sciences. Institute of Medicine. Dietary Reference Intakes (DRIs): Recommended Intakes for Individuals, Vitamins. 2004. http://iom.edu/en/Global/News%20Announcements/*/media/Files/Activity% 20Files/Nutrition/DRIs/DRISummaryListing2.ashx. Accessed May 12, 2010.
185. This reference has been deleted.
186. Neilson AP, Sapper TN, Janle EM, Rudolph R, Matusheski NV, and Ferruzzi MG. Chocolate matrix factors modulate the pharmacokinetic behavior of cocoa flavan-3-ol phase II metabolites following oral consumption by Sprague-Dawley rats. J Agric Food Chem 58: 6685-6691, 2010.
187. Neukam K, Stahl W, Tronnier H, Sies H, and Heinrich U. Consumption of flavanol-rich cocoa acutely increases microcirculation in human skin. Eur J Nutr 46: 53-56, 2007. (Pubitemid 46208261)
188. Njike VY, Faridi Z, Shuval K, Dutta S, Kay CD, West SG, Kris-Etherton PM, and Katz DL. Effects of sugar-sweetened and sugar-free cocoa on endothelial function in overweight adults. Int J Cardiol, 2009 [Epub ahead of print]; DOI: 10.1016/j.ijcard.2009.12.010.
189. Oba S, Nagata C, Nakamura K, Fujii K, Kawachi T, Takatsuka N, and Shimizu H. Consumption of coffee, green tea, oolong tea, black tea, chocolate snacks and the caffeine content in relation to risk of diabetes in Japanese men and women. Br J Nutr 103: 453-459, 2010.
190. Olivares M and Uauy R. Copper as an essential nutrient. Am J Clin Nutr 63: 791S-796S, 1996. (Pubitemid 26126601)
191. Oliviero T, Capuano E, Cammerer B, and Fogliano V. Influence of roasting on the antioxidant activity and HMF formation of a cocoa bean model systems. J Agric Food Chem 57: 147-152, 2009.
192. This reference has been deleted.
193. Osman JL and Sobal J. Chocolate cravings in American and Spanish individuals: biological and cultural influences. Appetite 47: 290-301, 2006. (Pubitemid 44602287)
194. Ostertag LM, O'Kennedy N, Kroon PA, Duthie GG, and de Roos B. Impact of dietary polyphenols on human platelet function-a critical review of controlled dietary intervention studies. Mol Nutr Food Res 54: 60-81, 2010.
195. Parker G, Parker I, and Brotchie H. Mood state effects of chocolate. J Affect Disord 92: 149-159, 2006.
196. Pearson DA, Holt RR, Rein D, Paglieroni T, Schmitz HH, and Keen CL. Flavanols and platelet reactivity. Clin Dev Immunol 12: 1-9, 2005. (Pubitemid 41647024)
197. Philips BJ, Coyle CH, Morrisroe SN, Chancellor MB, and Yoshimura N. Induction of apoptosis in human bladder cancer cells by green tea catechins. Biomed Res 30: 207-215, 2009.
198. Plotnick GD, Corretti MC, and Vogel RA. Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal. JAMA 278: 1682-1686, 1997. (Pubitemid 27509516)
199. Ramiro E, Franch A, Castellote C, Andres-Lacueva C, Izquierdo-Pulido M, and Castell M. Effect of Theobroma cacao flavonoids on immune activation of a lymphoid cell line. Br J Nutr 93: 859-866, 2005. (Pubitemid 43899564)
200. Ramiro-Puig E, and Castell M. Cocoa: antioxidant and immunomodulator. Br J Nutr 101: 931-40, 2009.
201. Ramiro-Puig E, Perez-Cano FJ, Ramirez-Santana C, Castellote C, Izquierdo-Pulido M, Permanyer J, Franch A, and Castell M. Spleen lymphocyte function modulated by a cocoa-enriched diet. Clin Exp Immunol 149: 535-42, 2007. (Pubitemid 47256148)
202. Ramiro-Puig E, Urpi-Sarda M, Perez-Cano FJ, Franch A, Castellote C, Andres-Lacueva C, Izquierdo-Pulido M, and Castell M. Cocoa-enriched diet enhances antioxidant enzyme activity and modulates lymphocyte composition in thymus from young rats. J Agric Food Chem 55: 6431-6438, 2007. (Pubitemid 47280014)
203. Ramos S. Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J Nutr Biochem 18: 427-442, 2007. (Pubitemid 46874924)
204. Rein D, Paglieroni TG, Pearson DA, Wun T, Schmitz HH, Gosselin R, and Keen CL. Cocoa and wine polyphenols modulate platelet activation and function. J Nutr 130: 2120S-2126S, 2000. (Pubitemid 30619393)
205. Rein D, Paglieroni TG, Wun T, Pearson DA, Schmitz HH, Gosselin R, and Keen CL. Cocoa inhibits platelet activation and function. Am J Clin Nutr 72: 30-35, 2000. (Pubitemid 30441653)
206. Reunanen A, Knekt P, Marniemi J, Maki J, Maatela J, and Aromaa A. Serum calcium, magnesium, copper and zinc and risk of cardiovascular death. Eur J Clin Nutr 50: 431-437, 1996. (Pubitemid 26246073)
207. Rios LY, Bennett RN, Lazarus SA, Remesy C, Scalbert A, and Williamson G. Cocoa procyanidins are stable during gastric transit in humans. Am J Clin Nutr 76: 1106-1110, 2002. (Pubitemid 35244685)
208. Rose N, Koperski S, and Golomb BA. Mood food: chocolate and depressive symptoms in a cross-sectional analysis. Arch Intern Med 170: 699-703, 2010.
209. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340: 115-126, 1999.
210. Roura E, Andres-Lacueva C, Estruch R, Lourdes Mata Bilbao M, Izquierdo-Pulido M, and Lamuela-Raventos RM. The effects of milk as a food matrix for polyphenols on the excretion profile of cocoa (f)-epicatechin metabolites in healthy human subjects. Br J Nutr 100: 846-851, 2008.
211. Roura E, Andres-Lacueva C, Estruch R, Mata-Bilbao ML, Izquierdo-Pulido M, Waterhouse AL, and Lamuela-Raventos RM. Milk does not affect the bioavailability of cocoa powder flavonoid in healthy human. Ann Nutr Metab 51: 493-498, 2007. (Pubitemid 351315915)
212. Rozin P, Levine E, and Stoess C. Chocolate craving and liking. Appetite 17: 199-212, 1991.
213. Ruzaidi A, Amin I, Nawalyah AG, Hamid M, and Faizul HA. The effect of Malaysian cocoa extract on glucose levels and lipid profiles in diabetic rats. J Ethnopharmacol 98: 55-60, 2005. (Pubitemid 40349167)
214. Saari JT. Copper deficiency and cardiovascular disease: role of peroxidation, glycation, and nitration. Can J Physiol Pharmacol 78: 848-855, 2000.
215. Schachinger V, Britten MB, and Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101: 1899-1906, 2000. (Pubitemid 30225269)
216. Schewe T, Steffen Y, and Sies H. How do dietary flavanols improve vascular function? A position paper. Arch Biochem Biophys 476: 102-106, 2008.
217. Schmitt CA and Dirsch VM. Modulation of endothelial nitric oxide by plant-derived products. Nitric Oxide 21: 77-91, 2009.
218. ScholeyAB, French SJ,Morris PJ, KennedyDO, MilneAL, and Haskell CF. Consumption of cocoa flavanols results in acute improvements in mood and cognitive performance during sustainedmental effort. J Psychopharmacol 24: 1505-1514, 2010.
219. Schramm DD, Karim M, Schrader HR, Holt RR, Kirkpatrick NJ, Polagruto JA, Ensunsa JL, Schmitz HH, and Keen CL. Food effects on the absorption and pharmacokinetics of cocoa flavanols. Life Sci 73: 857-869, 2003. (Pubitemid 36703249)
220. Schramm DD, Wang JF, Holt RR, Ensunsa JL, Gonsalves JL, Lazarus SA, Schmitz HH, German JB, and Keen CL. Chocolate procyanidins decrease the leukotriene-prostacyclin ratio in humans and human aortic endothelial cells. Am J Clin Nutr 73: 36-40, 2001. (Pubitemid 32016813)
221. Schroeter H, Bahia P, Spencer JP, Sheppard O, Rattray M, Cadenas E, Rice-Evans C, and Williams RJ. (f)-Epicatechin stimulates ERK-dependent cyclic AMP response element activity and up-regulates GluR2 in cortical neurons. J Neurochem 101: 1596-1606, 2007. (Pubitemid 46848841)
222. Schroeter H, Heiss C, Balzer J, Kleinbongard P, Keen CL, Hollenberg NK, Sies H, Kwik-Uribe C, Schmitz HH, and Kelm M. (f)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci USA 103: 1024-1029, 2006. (Pubitemid 43212215)
223. Schwab US, Maliranta HM, Sarkkinen ES, Savolainen MJ, Kesaniemi YA, and Uusitupa MI. Different effects of palmitic and stearic acid-enriched diets on serum lipids and lipoproteins and plasma cholesteryl ester transfer protein activity in healthy young women. Metabolism 45: 143-149, 1996. (Pubitemid 26102607)
224. Seligson FH, Krummel DA, and Apgar JL. Patterns of chocolate consumption. Am J Clin Nutr 60: 1060S-1064S, 1994.
225. Selmi C, Cocchi CA, Lanfredini M, Keen CL, and Gershwin ME. Chocolate at heart: the anti-inflammatory impact of cocoa flavanols. Mol Nutr Food Res 52: 1340-1348, 2008.
226. Selmi C, Mao TK, Keen CL, Schmitz HH, and Eric Gershwin M. The anti-inflammatory properties of cocoa flavanols. J Cardiovasc Pharmacol 47 Suppl 2: S163-S171; discussion S172-S176, 2006. (Pubitemid 44620206)
227. Serafini M, Bugianesi R, Maiani G, Valtuena S, De Santis S, and Crozier A. Plasma antioxidants from chocolate. Nature 424: 1013, 2003. (Pubitemid 37064293)
228. Sessa WC. eNOS at a glance. J Cell Sci 117: 2427-2429, 2004.
229. Shapiro H, Lev S, Cohen J, and Singer P. Polyphenols in the prevention and treatment of sepsis syndromes: rationale and pre-clinical evidence. Nutrition 25: 981-997, 2009.
230. Sharma SD, Meeran SM, and Katiyar SK. Proanthocyanidins inhibit in vitro and in vivo growth of human non-small cell lung cancer cells by inhibiting the prostaglandin E(2) and prostaglandin E(2) receptors. Mol Cancer Ther 9: 569-580, 2010.
231. Shiina Y, Funabashi N, Lee K, Murayama T, Nakamura K, Wakatsuki Y, Daimon M, and Komuro I. Acute effect of oral flavonoid-rich dark chocolate intake on coronary circulation, as compared with non-flavonoid white chocolate, by transthoracic Doppler echocardiography in healthy adults. Int J Cardiol 131: 424-429, 2009.
232. Shively CA and Tarka SM Jr. Methylxanthine composition and consumption patterns of cocoa and chocolate products. Prog Clin Biol Res 158: 149-178, 1984.
233. Sies H, Schewe T, Heiss C, and Kelm M. Cocoa polyphenols and inflammatory mediators. Am J Clin Nutr 81: 304S-312S, 2005.
234. Singh M, Arseneault M, Sanderson T, Murthy V, and Ramassamy C. Challenges for research on polyphenols from foods in Alzheimer's disease: bioavailability, metabolism, and cellular and molecular mechanisms. J Agric Food Chem 56: 4855-4873, 2008. (Pubitemid 352039080)
235. Smit HJ and Blackburn RJ. Reinforcing effects of caffeine and theobromine as found in chocolate. Psychopharmacology (Berl) 181: 101-106, 2005. (Pubitemid 41440920)
236. Smit HJ, Gaffan EA, and Rogers PJ. Methylxanthines are the psycho-pharmacologically active constituents of chocolate. Psychopharmacology (Berl) 176: 412-419, 2004. (Pubitemid 40012749)
237. Song Y, Manson JE, Cook NR, Albert CM, Buring JE, and Liu S. Dietary magnesium intake and risk of cardiovascular disease among women. Am J Cardiol 96: 1135-1141, 2005. (Pubitemid 41416609)
238. Sorond FA, Lipsitz LA, Hollenberg NK, and Fisher ND. Cerebral blood flow response to flavanol-rich cocoa in healthy elderly humans. Neuropsychiatr Dis Treat 4: 433-440, 2008. (Pubitemid 351711937)
239. Spadafranca A, Martinez Conesa C, Sirini S, and Testolin G. Effect of dark chocolate on plasma epicatechin levels, DNA resistance to oxidative stress and total antioxidant activity in healthy subjects. Br J Nutr 103: 1008-1014, 2010.
240. Spencer JP. The interactions of flavonoids within neuronal signalling pathways. Genes Nutr 2: 257-273, 2007.
241. Spencer JP. Flavonoids: modulators of brain function? Br J Nutr 99 E Suppl 1: ES60-ES77, 2008.
242. Spencer JP. Flavonoids and brain health: multiple effects underpinned by common mechanisms. Genes Nutr 4: 243-250, 2009.
243. Spencer JP, Abd-el-Mohsen MM, and Rice-Evans C. Cellular uptake and metabolism of flavonoids and their metabolites: implications for their bioactivity. Arch Biochem Biophys 423: 148-161, 2004. (Pubitemid 38198224)
244. Stahl L, Miller KB, Apgar J, Sweigart DS, Stuart DA, McHale N, Ou B, Kondo M, and Hurst WJ. Preservation of cocoa antioxidant activity, total polyphenols, flavan-3-ols, and procyanidin content in foods prepared with cocoa powder. J Food Sci 74: C456-C461, 2009.
245. Steffen Y, Jung T, Klotz LO, Schewe T, Grune T, and Sies H. Protein modification elicited by oxidized low-density lipoprotein (LDL) in endothelial cells: protection by (f)-epicatechin. Free Radic Biol Med 42: 955-970, 2007. (Pubitemid 46356890)
246. Steffen Y, Schewe T, and Sies H. Myeloperoxidasemediated LDL oxidation and endothelial cell toxicity of oxidized LDL: attenuation by (f)-epicatechin. Free Radic Res 40: 1076-1085, 2006. (Pubitemid 44480548)
247. Steffen Y, Schewe T, and Sies H. (f)-Epicatechin elevates nitric oxide in endothelial cells via inhibition of NADPH oxidase. Biochem Biophys Res Commun 359: 828-833, 2007. (Pubitemid 46899027)
248. Steinberg FM, Bearden MM, and Keen CL. Cocoa and chocolate flavonoids: implications for cardiovascular health. J Am Diet Assoc 103: 215-223, 2003. (Pubitemid 38375924)
249. Stipanuk M. Biochemical and Physiological Aspects of Human Nutrition. Philadelphia: Saunders Company, 2000.
250. Stoclet JC, Chataigneau T, Ndiaye M, Oak MH, El Bedoui J, Chataigneau M, and Schini-Kerth VB. Vascular protection by dietary polyphenols. Eur J Pharmacol 500: 299-313, 2004. (Pubitemid 39304017)
251. Strandberg TE, Strandberg AY, Pitkala K, Salomaa VV, Tilvis RS, and Miettinen TA. Chocolate, well-being and health among elderly men. Eur J Clin Nutr 62: 247-253, 2008. (Pubitemid 351234260)
252. Suganuma M, Okabe S, Kai Y, Sueoka N, Sueoka E, and Fujiki H. Synergistic effects of (f)-epigallocatechin gallate with (f)-epicatechin, sulindac, or tamoxifen on cancerpreventive activity in the human lung cancer cell line PC-9. Cancer Res 59: 44-47, 1999. (Pubitemid 29062952)
253. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr., and Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101: 948-954, 2000. (Pubitemid 30131694)
254. Sydow K, Mondon CE, and Cooke JP. Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA. Vasc Med 10 Suppl 1: S35-S43, 2005. (Pubitemid 43137266)
255. Taubert D, Berkels R, Roesen R, and Klaus W. Chocolate and blood pressure in elderly individuals with isolated systolic hypertension. JAMA 290: 1029-1030, 2003. (Pubitemid 37430441)
256. Taubert D, Roesen R, Lehmann C, Jung N, and Schomig E. Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide: a randomized controlled trial. JAMA 298: 49-60, 2007. (Pubitemid 47026770)
257. Tschop M, Smiley DL, and Heiman ML. Ghrelin induces adiposity in rodents. Nature 407: 908-913, 2000.
258. U.S. Food and Drug Administration. 2010. CFR-Code of Federal Regulations Title 21. www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart = 163& showFR = 1, accessed September 20, 2010.
259. Uauy R, Olivares M, and Gonzalez M. Essentiality of copper in humans. Am J Clin Nutr 67: 952S-959S, 1998. (Pubitemid 28198816)
260. Ueshima K. Magnesium and ischemic heart disease: a review of epidemiological, experimental, and clinical evidences. Magnes Res 18: 275-284, 2005. (Pubitemid 43287483)
261. Umesawa M, Iso H, Date C, Yamamoto A, Toyoshima H, Watanabe Y, Kikuchi S, Koizumi A, Kondo T, Inaba Y, Tanabe N, and Tamakoshi A. Relations between dietary sodium and potassium intakes and mortality from cardiovascular disease: the Japan Collaborative Cohort Study for Evaluation of Cancer Risks. Am J Clin Nutr 88: 195-202, 2008. (Pubitemid 351988704)
262. United States Department of Agriculture. Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans. 2010.
263. Urpi-Sarda M, Llorach R, Khan N, Monagas M, Rotches-Ribalta M, Lamuela-Raventos R, Estruch R, Tinahones FJ, and Andres-Lacueva C. Effect of milk on the urinary excretion of microbial phenolic acids after cocoa powder consumption in humans. J Agric Food Chem 58: 4706-4711, 2010.
264. Urpi-Sarda M, Ramiro-Puig E, Khan N, Ramos-Romero S, Llorach R, Castell M, Gonzalez-Manzano S, Santos-Buelga C, and Andres-Lacueva C. Distribution of epicatechin metabolites in lymphoid tissues and testes of young rats with a cocoa-enriched diet. Br J Nutr 103: 1393-1397, 2010.
265. Victor VM, Rocha M, Sola E, Banuls C, Garcia-Malpartida K, and Hernandez-Mijares A. Oxidative stress, endothelial dysfunction and atherosclerosis. Curr Pharm Des 15: 2988-3002, 2009.
266. Vogel RA. Measurement of endothelial function by brachial artery flow-mediated vasodilation. Am J Cardiol 88: 31E-34E, 2001. (Pubitemid 32721982)
267. Wan Y, Vinson JA, Etherton TD, Proch J, Lazarus SA, and Kris-Etherton PM. Effects of cocoa powder and dark chocolate on LDL oxidative susceptibility and prostaglandin concentrations in humans. Am J Clin Nutr 74: 596-602, 2001. (Pubitemid 33015145)
268. Wang JF, Schramm DD, Holt RR, Ensunsa JL, Fraga CG, Schmitz HH, and Keen CL. A dose-response effect from chocolate consumption on plasma epicatechin and oxidative damage. J Nutr 130: 2115S-2119S, 2000. (Pubitemid 30619392)
269. Wang-Polagruto JF, Villablanca AC, Polagruto JA, Lee L, Holt RR, Schrader HR, Ensunsa JL, Steinberg FM, Schmitz HH, and Keen CL. Chronic consumption of flavanol-rich cocoa improves endothelial function and decreases vascular cell adhesion molecule in hypercholesterolemic postmenopausal women. J Cardiovasc Pharmacol 47 Suppl 2: S177-S186; discussion S206-S209, 2006. (Pubitemid 44620209)
270. Weickert MO and Pfeiffer AF. Metabolic effects of dietary fiber consumption and prevention of diabetes. J Nutr 138: 439-442, 2008. (Pubitemid 351355237)
271. Weisburger JH. Antimutagenesis and anticarcinogenesis, from the past to the future. Mutat Res 480-481: 23-35, 2001. (Pubitemid 32744810)
272. Weisburger JH. Chemopreventive effects of cocoa polyphenols on chronic diseases. Exp Biol Med (Maywood) 226: 891-897, 2001.
273. Welsch CA, Lachance PA, and Wasserman BP. Dietary phenolic compounds: inhibition of Na+-dependent Dglucose uptake in rat intestinal brush border membrane vesicles. J Nutr 119: 1698-1704, 1989. (Pubitemid 20028920)
274. Widlansky ME, Gokce N, Keaney JF Jr., and Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol 42: 1149-1160, 2003. (Pubitemid 37188333)
275. Williams MJ, Sutherland WH, McCormick MP, de Jong SA, Walker RJ, and Wilkins GT. Impaired endothelial function following a meal rich in used cooking fat. J Am Coll Cardiol 33: 1050-1055, 1999.
276. Williams S, Tamburic S, and Lally C. Eating chocolate can significantly protect the skin from UV light. J Cosmet Dermatol 8: 169-173, 2009.
277. Williamson G. Bioavailability and health effects of cocoa polyphenols. Inflammopharmacology 17: 111, 2009.
278. Willner P, Benton D, Brown E, Cheeta S, Davies G, Morgan J, and Morgan M. "Depression" increases "craving" for sweet rewards in animal and human models of depression and craving. Psychopharmacology (Berl) 136: 272-283, 1998. (Pubitemid 28143177)
279. Wober C, Holzhammer J, Zeitlhofer J, Wessely P, and Wober-Bingol C. Trigger factors of migraine and tensiontype headache: experience and knowledge of the patients. J Headache Pain 7: 188-195, 2006. (Pubitemid 46206332)
280. Woodside JV, McKinley MC, and Young IS. Saturated and trans fatty acids and coronary heart disease. Curr Atheroscler Rep 10: 460-466, 2008.
281. World Cocoa Foundation. How chocolate is made. www.worldcocoafoundation. org/learn-about-cocoa/tree-totable/how-chocolate-is-made.asp, accessed January 10, 2010.
282. Wright LE and Castell DO. The adverse effect of chocolate on lower esophageal sphincter pressure. Am J Dig Dis 20: 703-707, 1975.
283. Yang CS, Wang X, Lu G, and Picinich SC. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 9: 429-439, 2009.
284. Yeboah J, Crouse JR, Hsu FC, Burke GL, and Herrington DM. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation 115: 2390-2397, 2007. (Pubitemid 46717961)
285. Yeboah J, FolsomAR, Burke GL, Johnson C, Polak JF, PostW, Lima JA, Crouse JR, and Herrington DM. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation 120: 502-509, 2009.
286. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, and Investigators IS. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364: 937-952, 2004. (Pubitemid 39208455)
287. Zadak Z, Hyspler R, Ticha A, Hronek M, Fikrova P, Rathouska J, Hrnciarikova D, and Stetina R. Antioxidants and vitamins in clinical conditions. Physiol Res 58 Suppl 1: S13-S17, 2009.
288. Zellner DA, Garriga-Trillo A, Centeno S, and Wadsworth E. Chocolate craving and the menstrual cycle. Appetite 42: 119-21, 2004. (Pubitemid 38229690)
289. Zellner DA, Garriga-Trillo A, Rohm E, Centeno S, and Parker S. Food liking and craving: A cross-cultural approach. Appetite 33: 61-70, 1999. (Pubitemid 29401750)